Stock 301408 ANHUI HUAREN HEALTH PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Anhui Huaren Health Pharmaceutical Co., Ltd.

Equities

301408

CNE100005YT4

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
12.4 CNY +1.14% Intraday chart for Anhui Huaren Health Pharmaceutical Co., Ltd. -1.90% -22.26%
04-28 Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 Anhui Huaren Health Pharmaceutical Co., Ltd. Approves the Election of Independent Directors CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Anhui Huaren Health Pharmaceutical Co., Ltd. Approves the Election of Independent Directors
Certain A Shares of Anhui Huaren Health Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 2-MAR-2024.
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Anhui Huaren Health Pharmaceutical Co., Ltd.(XSEC:301408) added to S&P Global BMI Index
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Anhui Huaren Health Pharmaceutical Co., Ltd. completed the acquisition of Jiangsu Shenhua Pharmaceutical Co., Ltd. from Full Health (Hong Kong) Limited.
Anhui Huaren Health Pharmaceutical Co., Ltd. signed a letter of intent to acquire 60% stake in Zhoushan Liken Pharmaceutical Chain Co Ltd from Wang Xiangan and Zhejiang Free Trade Zone Xueyuan Project Investment Partnership for approximately CNY 110 million.
Anhui Huaren Health Pharma to Buy Smaller Peer For 347 Million Yuan
Anhui Huaren Health Pharmaceutical Co., Ltd. signed an agreement to acquire Jiangsu Shenhua Pharmaceutical Co., Ltd. from Full Health (Hong Kong) Limited for approximately CNY 350 million.
Huaren Health Pharma Unit Gets Drug Production License
Anhui Huaren Health Pharmaceutical Co., Ltd. Elects Yang Ce as A Non-Independent Director
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301408 Stock
  4. News Anhui Huaren Health Pharmaceutical Co., Ltd.
  5. Other languages